We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-2.1%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.12B
AUM Growth
-$506M
Cap. Flow
-$1.33B
Cap. Flow %
-25.88%
Top 10 Hldgs %
36.5%
Holding
171
New
28
Increased
20
Reduced
18
Closed
38

Top Buys

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$561M
2
WGS icon
GeneDx Holdings
WGS
+$144M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$39.4M
4
GKOS icon
Glaukos
GKOS
+$34.3M
5
AERI
Aerie Pharmaceuticals
AERI
+$31.4M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$54.4M
2
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$54.1M
3
QDEL icon
QuidelOrtho
QDEL
+$52.4M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$45.3M
5
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$42.5M

Sector Composition

Rank Sector Weight
1 Healthcare 66.12%
2 Financials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTCR
101
DELISTED
Metacrine, Inc. Common Stock
MTCR
$952K 0.02%
277,469
– –
QSIAW
102
DELISTED
Quantum-Si Inc Warrant
QSIAW
$677K 0.01%
333,333
– –
NUVB.WS
103
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$427K 0.01%
166,666
– –
SLGCW
104
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$414K 0.01%
+120,000
New +$370K
SNRHW
105
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$355K 0.01%
+500,000
New +$391K
TLSIW icon
106
TriSalus Life Sciences Warrant
TLSIW
$25.5M
$273K 0.01%
+333,333
New +$309K
PKBOW
107
DELISTED
Peak Bio, Inc. Warrant
PKBOW
$232K ﹤0.01%
+362,500
New +$288K
SRZNW icon
108
Surrozen Inc Warrant
SRZNW
$75.6K
$190K ﹤0.01%
+166,666
New +$229K
REVHW
109
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$186K ﹤0.01%
+200,000
New +$228K
OHPAW
110
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$80K ﹤0.01%
+125,000
New +$94.3K
WINT
111
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
ADVM
112
DELISTED
Adverum Biotechnologies
ADVM
– –
-282,700
Closed -$9.89M
AGL icon
113
Agilon Health
AGL
$1.64B
– –
-12,000
Closed -$12.2M
ARDX icon
114
Ardelyx
ARDX
$1.25B
– –
-3,811,554
Closed -$28.9M
BLUE
115
DELISTED
bluebird bio
BLUE
– –
-37,079
Closed -$15.4M
BMEA icon
116
Biomea Fusion
BMEA
$91.1M
– –
-248,447
Closed -$3.88M
BVS icon
117
Bioventus
BVS
$843M
– –
-778,567
Closed -$13.7M
DYN icon
118
Dyne Therapeutics
DYN
$4.24B
– –
-787,000
Closed -$16.6M
FOLD
119
DELISTED
Amicus Therapeutics
FOLD
– –
-2,941,492
Closed -$28.4M
LKFT
120
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
– –
-657,005
Closed -$45.3M
GLUE icon
121
Monte Rosa Therapeutics
GLUE
$1.91B
– –
-350,000
Closed -$7.95M
IMCR icon
122
Immunocore
IMCR
$1.72B
– –
-360,966
Closed -$14.1M
INSM icon
123
Insmed
INSM
$22.7B
– –
-200,000
Closed -$5.69M
JANX icon
124
Janux Therapeutics
JANX
$950M
– –
-700,000
Closed -$17.5M
LFST icon
125
Lifestance Health
LFST
$4.15B
– –
-400,000
Closed -$11.1M
2 3 4
5
6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2021 Portfolio in Review

As of Q3 2021, Deerfield Management held 171 positions worth $5.12B, down 9% from $5.63B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Deerfield Management withdrew a net $1.33B in Q3 2021, closing 38 positions and reducing 18 holdings. Its most notable exit was Zimmer Biomet, an estimated $54.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 68% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in Nuvalent worth $436M.

  • Deerfield Management's largest Q3 2021 buy was Nuvalent: 19,341,024 shares worth $436M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2021, an estimated $39.4M increase.
  • Deerfield Management's biggest Q3 2021 reduction was BioCryst Pharmaceuticals, cutting an estimated $41M.
  • Deerfield Management fully exited Zimmer Biomet in Q3 2021, selling an estimated $54.4M.
  • Deerfield Management's ten largest holdings make up 37% of its $5.12B portfolio in Q3 2021.
  • Deerfield Management opened 28 new positions and closed 38 in Q3 2021.
  • Deerfield Management's portfolio value fell 9% quarter-over-quarter to $5.12B.

Based on Deerfield Management's 13F filing for Q3 2021, filed 15 Nov 2021.